AI/Machine Learning: Regulation, Development, and Real-World Performance Evaluation
Webinar | 03.22.22, 12:30 PM UTC - 4:00 PM UTC
On March 22, 2022 from 12:30 – 4:00 pm (EDT) the Duke-Margolis Center of Health Policy, with participation from the U.S. Food and Drug Administration (FDA) speakers and panelists, will hold a public webinar to spotlight updates and progress made since the release of FDA’s Artificial Intelligence/Machine Learning Action Plan in early 2021.
There will be a fireside chat between Jeff Shuren, FDA’s director of the Center for Devices and Radiological Health (CRDH), and Mark McClellan, director of Duke-Margolis, followed by three panel discussions focused on the following topics:
- Overarching frameworks for regulating and evaluating AI
- Good machine learning practices (GMLP)
- Post-market evaluation of AI/ML SaMD
The webinar will end with a business roundtable discussion on how developers and health care systems are considering these issues.
For more information, please visit these areas: Artificial Intelligence
Participants
Partner & CHS Managing Director
She/Her/Hers
Insights
Webinar | 01.23.25
Trump Administration and What it Means for Businesses Outside the US
On 23 January 2025 at 16:00 CET, Crowell will host a webinar on the new Trump Administration and what it means for businesses outside the US. It will focus, in particular, on the Trump Administration’s policy objectives, how they will be implemented, and the legal and real-world impacts. By the date of the webinar, the new Trump Administration is expected to have issued its first Executive Orders, and there will be more clarity on their scope and content.
Webinar | 01.22.25
Webinar | 01.09.25
What Will the New Year Bring for Government Contractors in 2025?
Webinar | 01.08.25
